Abstract

Background and PurposeBK channels play important roles in various physiological and pathophysiological processes and thus have been the target of several drug development programmes focused on creating new efficacious BK channel openers, such as the GoSlo‐SR compounds. However, the effect of GoSlo‐SR compounds on vascular smooth muscle has not been studied. Therefore, we tested the hypothesis that GoSlo‐SR compounds dilate arteries exclusively by activating BK channels.Experimental ApproachExperiments were performed on rat Gracilis muscle, saphenous, mesenteric and tail arteries using isobaric and isometric myography, sharp microelectrodes, digital droplet PCR and the patch‐clamp technique.Key ResultsGoSlo‐SR compounds dilated isobaric and relaxed and hyperpolarised isometric vessel preparations and their effects were abolished after (a) functionally eliminating K+ channels by pre‐constriction with 50 mM KCl or (b) blocking all K+ channels known to be expressed in vascular smooth muscle. However, these effects were not blocked when BK channels were inhibited. Surprisingly, the Kv7 channel inhibitor XE991 reduced their effects considerably, but neither Kv1 nor Kv2 channel blockers altered the inhibitory effects of GoSlo‐SR. However, the combined blockade of BK and Kv7 channels abolished the GoSlo‐SR‐induced relaxation. GoSlo‐SR compounds also activated Kv7.4 and Kv7.5 channels expressed in HEK 293 cells.Conclusion and ImplicationsThis study shows that GoSlo‐SR compounds are effective relaxants in vascular smooth muscle and mediate their effects by a combined activation of BK and Kv7.4/Kv7.5 channels. Activation of Kv1, Kv2 or Kv7.1 channels or other vasodilator pathways seems not to be involved.

Highlights

  • Large conductance, calcium-activated potassium channels (BK channels or KCa 1.1 channels) are expressed in all tissues and organs

  • This study shows that GoSlo-SR compounds are effective relaxants in vascular smooth muscle and mediate their effects by a combined activation of BK and Kv7.4/Kv7.5 channels

  • Having established the transcriptional expression of KCNQ, we examined the effects of a Kv7 channel blocker, XE991 (3 × 10−6 M; Greenwood & Ohya, 2009) on isobaric preparations pressurised to 80 mmHg

Read more

Summary

| INTRODUCTION

Calcium-activated potassium channels (BK channels or KCa 1.1 channels) are expressed in all tissues and organs They contribute to a wide array of physiological functions in the kidney and neurons (Latorre et al, 2017), as well as in the heart (Balderas, Zhang, Stefani, & Toro, 2015) and both vascular (Brayden & Nelson, 1992) and visceral smooth muscle (Burdyga & Wray, 2005). GoSlo-SR compounds reliably activate BK channels in electrophysiological experiments, their effects on the contractility of intact smooth muscle tissues appear variable. GoSlo-SR-5-130 decreased spontaneous contractility and its effects (like those on the rabbit bladder) were reversed by iberiotoxin (Hannigan et al, 2016), suggesting that these compounds mediate their effects exclusively by activating BK channels. Given that the contractility of vascular smooth muscle is modulated by a variety of K channels including BK channels (Tykocki, Boerman, & Jackson, 2017), we tested the hypothesis that GoSlo-SR compounds dilate rat arteries exclusively by activating BK channels

| METHODS
| RESULTS
Findings
| DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call